Answers are grounded in this paper and cite their sources.
We are very grateful to Dr Tavadia and colleagues for highlighting the link between leucocytoclastic vasculitis and influenza immunization.1 We recently had cause to speculate whether influenza immunization had been responsible for a fulminant bullous necrotizing cutaneous vasculitis of the lower legs in a 64‐year‐old woman (Fig. 1) who had received inactivated influenza vaccine (split virion) 10 days earlier. Histology showed the changes of leucocytoclastic vasculitis. There was no evidence of systemic involvement. Despite prednisolone 40 mg daily her bullae progressed to deep ulcers which then took more than 3 months to heal. Since such a large proportion of the elderly population in the UK receives influenza immunization, a temporal association between immunization and any acute illness is more likely than not to be coincidental. We were therefore reluctant to attribute our patient's vasculitis to this before we had excluded other causes. There were, however, no obvious alternative antecedent events to account for her vasculitis. Of the numerous oral medications she had been taking, only bendrofluazide, introduced 6 months earlier, was thought to be a possible aetiological factor. This was discontinued. A screen for other causes of vasculitis was negative. Dermatologists should be aware that influenza immunization must now be included in the large list of precipitants of cutaneous vasculitis.
No takes yet. Share an insight, caveat, or question.
Walker et al. (2004) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: